Tag: ers

Regulating gene-editing technology

A chara, – As CEO of ERS Genomics, founded by Emmanuelle Charpentier, Nobel Prize winner for the discovery of Crispr/Cas9, I’d like to echo the sentiments of Dr Thomas McLoughlin (Letters, December 16th), who writes: “Crispr has the potential to revolutionise agriculture, environment and medicine for the benefit of people…

Continue Reading Regulating gene-editing technology

Potter Clarkson and ERS Genomics to join forces with eureKARE on the eureKAWARDS

Potter Clarkson and ERS Genomics to join forces with eureKARE on the eureKAWARDS Potter Clarkson to offer the winner a Kick-StartiP consultancy ERS Genomics to provide the most promising CRISPR/Cas9 team with a complimentary three-year CRISPR/Cas9 license Luxembourg and Paris, France – 14 September 2021: eureKARE (“the Company”), a pioneering…

Continue Reading Potter Clarkson and ERS Genomics to join forces with eureKARE on the eureKAWARDS

ERS Genomics Licenses CRISPR-Cas9 Patent And Technology To Cellular Engineering Technologies – Food, Drugs, Healthcare, Life Sciences

India: ERS Genomics Licenses CRISPR-Cas9 Patent And Technology To Cellular Engineering Technologies 02 September 2021 Khurana and Khurana To print this article, all you need is to be registered or login on Mondaq.com. Recently, Dublin, Ireland-based biotechnology company, ERS Genomics Limited (“ERS”),…

Continue Reading ERS Genomics Licenses CRISPR-Cas9 Patent And Technology To Cellular Engineering Technologies – Food, Drugs, Healthcare, Life Sciences

Global Roundup: Cellink Transitions into BICO

Sweden’s Cellink AB has rebranded to BICO, the world’s first Bio-Convergence company. BICO is the parent company overseeing the 11 subsidiaries, including Cellink Bioprinting. This transition is expected to enable BICO and its subsidiaries to innovate through the group’s shared bio convergence agenda, which entails investments in bioengineering, technology development,…

Continue Reading Global Roundup: Cellink Transitions into BICO

ERS Genomics and Cellular Engineering Technologies collaborating

ERS Genomics and Cellular Engineering Technologies have entered into a CRISPR-Cas9 license agreement. Under the agreement, Cellular Engineering Technologies licences the rights from Dublin-based ERS Genomics Ltd. to develop, manufacture and commercialise next-generation stem cell lines using the CRISPR-Cas9 technology initially patented by Emmanuelle Charpentier. Cell manufacturing specialist Cellular Engineering…

Continue Reading ERS Genomics and Cellular Engineering Technologies collaborating